OPSUMIT
Actelion Pharmaceuticals Ltd
| Research |
OneLook
Acronym Finder
|
| Serial Number | 85329499 |
| Registration Number | 4056510 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Cheryl Foytlin |
| Attorney Name | Cheryl Foytlin |
| Attorney Docket Number | T41866US1 |
| Law Office Assigned | M70 |
| Employee Name | HAMMEL, LAURA A |
Timeline
| 2011-05-25 | Application Filed |
| 2011-08-30 | Published for Opposition |
| 2011-11-15 | Trademark Registered |
| 2017-02-07 | Location: TMO LAW OFFICE 116 |
| 2017-02-07 | Status: Live/Registered |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Actelion Pharmaceuticals Ltd |
| Entity Statement | société anonyme (sa) |
| Address | Gewerbestrasse 16 Allschwil CH CH-4123 |
| Legal Entity Type | |
| Legal Entity State | CH |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases; Pharmaceutical preparations for the treatment of inflammatory diseases; [ Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of auto-immune disorders; Pharmaceutical preparations for the treatment of digital ulcers ] |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2011-05-28 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2011-05-31 | 2 NWOS I:Incoming Correspondence |
| TEAS VOLUNTARY AMENDMENT RECEIVED | 2011-06-23 | 3 PARI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2011-06-29 | 4 ALIE A:Allowance for Publication |
| APPLICANT AMENDMENT PRIOR TO EXAMINATION - ENTERED | 2011-07-07 | 5 AMPX O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2011-07-19 | 6 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2011-07-20 | 7 CNSA O:Outgoing Correspondence |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2011-07-27 | 8 PREV O:Outgoing Correspondence |
| PUBLISHED FOR OPPOSITION | 2011-08-30 | 9 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2011-08-30 | 10 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2011-11-15 | 11 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2013-05-30 | 12 TCCA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2016-11-15 | 13 REM1 E:E-Mail |
| TEAS SECTION 8 RECEIVED | 2016-11-30 | 14 ES8R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2017-02-07 | 15 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (6-YR) ACCEPTED | 2017-02-07 | 16 8.OK O:Outgoing Correspondence |
| NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | 2017-02-07 | 17 NAS8 E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2018-03-06 | 18 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2018-03-06 | 19 ARAA I:Incoming Correspondence |
| COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | 2020-11-15 | 20 REM2 E:E-Mail |
| TEAS SECTION 8 & 9 RECEIVED | 2021-11-10 | 21 E89R I:Incoming Correspondence |
| CASE ASSIGNED TO POST REGISTRATION PARALEGAL | 2022-03-21 | 22 APRE A:Allowance for Publication |
| REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | 2022-03-21 | 23 89AG O:Outgoing Correspondence |
| REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | 2022-03-21 | 24 RNL1 Q: |
| NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | 2022-03-21 | 25 NA89 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OPSUMIT 90653209 not registered Live/Pending |
Actelion Pharmaceuticals Ltd. 2021-04-18 |
 OPSUMIT 85727907 4589297 Live/Registered |
Actelion Pharmaceuticals Ltd 2012-09-13 |
 OPSUMIT 85329499 4056510 Live/Registered |
Actelion Pharmaceuticals Ltd 2011-05-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 